198 related articles for article (PubMed ID: 31118387)
1. Nivolumab-induced Myocarditis Successfully Treated with Corticosteroid Therapy: A Case Report and Review of the Literature.
Matsuo K; Ishiguro T; Najama T; Shimizu Y; Kobayashi Y; Mutou M
Intern Med; 2019 Aug; 58(16):2367-2372. PubMed ID: 31118387
[TBL] [Abstract][Full Text] [Related]
2. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
[TBL] [Abstract][Full Text] [Related]
3. [Fulminant myocarditis caused by nivolumab treatment for non-small cell lung cancer (NSCLC): a case report].
Tan KX; Li CY; Zhang JY; Cui HJ; Shen W; Zhang X; Sun CY; Jiang XJ; Zheng SY; Li J; Xue CX
Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1047-1048. PubMed ID: 33342162
[No Abstract] [Full Text] [Related]
4. Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.
Sarocchi M; Grossi F; Arboscello E; Bellodi A; Genova C; Dal Bello MG; Rijavec E; Barletta G; Rossi G; Biello F; Ghigliotti G; Canepa M; Mussap M; Brunelli C; Spallarossa P
Oncologist; 2018 Aug; 23(8):936-942. PubMed ID: 29567824
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung.
Semper H; Muehlberg F; Schulz-Menger J; Allewelt M; Grohé C
Lung Cancer; 2016 Sep; 99():117-9. PubMed ID: 27565924
[TBL] [Abstract][Full Text] [Related]
6. Bicytopenia in Primary Lung Melanoma Treated with Nivolumab.
Takahashi A; Kubo A; Mizuno S; Kasai K; Asai N; Yonezawa T; Kosaka K; Nishimura M; Tanaka H; Yokoe N; Tsuzuki T; Takami A; Yamaguchi E
Intern Med; 2019 Mar; 58(6):827-831. PubMed ID: 30449777
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy- A double Edged Sword; A case of Fatal Myocarditis and Complete Response.
Peters N; Greally M; Breen K; Fabre A; Blazkova S
Ir Med J; 2019 May; 112(5):937. PubMed ID: 31411390
[No Abstract] [Full Text] [Related]
8. Nivolumab-induced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer.
Tan JL; Mugwagwa AN; Cieslik L; Joshi R
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31300602
[TBL] [Abstract][Full Text] [Related]
9. Fulminant Myocarditis for Non-small-cell Carcinoma of the Lung with Nivolumab and Ipilimumab Plus Chemotherapy.
Nishimura T; Ninomiya K; Nakashima M; Akagi S; Kuribayashi T; Higo H; Hotta K; Maeda Y; Ito H; Kiura K
Intern Med; 2023 May; 62(9):1319-1322. PubMed ID: 36130891
[TBL] [Abstract][Full Text] [Related]
10. [Dermatomyositis with squamous cell carcinoma of the lungs secondary to nivolumab treatment: a case report].
Miyashita K; Kajikawa H; Utsunomiya T; Hosaka M; Naito Y; Tomimoto H
Rinsho Shinkeigaku; 2020 Nov; 60(11):768-772. PubMed ID: 33115992
[TBL] [Abstract][Full Text] [Related]
11. Durvalumab-associated Late-onset Myocarditis Successfully Treated with Corticosteroid Therapy.
Maetani T; Hamaguchi T; Nishimura T; Marumo S; Fukui M
Intern Med; 2022 Feb; 61(4):527-531. PubMed ID: 34433717
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma.
Tokumo K; Masuda T; Miyama T; Miura S; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Yoshida T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Lung Cancer; 2018 May; 119():21-24. PubMed ID: 29656748
[TBL] [Abstract][Full Text] [Related]
13. Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma.
Mishima Y; Fukaishi T; Inase N; Isogai S
Intern Med; 2019 Mar; 58(5):693-697. PubMed ID: 30449786
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Nivolumab-Induced Isolated Adrenocorticotropic Hormone Deficiency Presenting Dyspnea].
Ito K; Uchida T; Manabe Y; Miyazaki Y; Itoh H; Mishina M; Okuno H
Hinyokika Kiyo; 2018 Oct; 64(10):391-395. PubMed ID: 30543736
[TBL] [Abstract][Full Text] [Related]
15. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
Shibata C; Kato J; Toda N; Imai M; Fukumura Y; Arai J; Kurokawa K; Kondo M; Takagi K; Kojima K; Ohki T; Seki M; Yoshida M; Suzuki A; Tagawa K
J Med Case Rep; 2019 Jun; 13(1):168. PubMed ID: 31153385
[TBL] [Abstract][Full Text] [Related]
17. Effect of Systemic Corticosteroid Therapy on the Efficacy and Safety of Nivolumab in the Treatment of Non-Small-Cell Lung Cancer.
Umehara K; Yama K; Goto K; Wakamoto A; Hatsuyama T; Honjo O; Saikai T; Fujita A; Sato H
Cancer Control; 2021; 28():1073274820985790. PubMed ID: 33733906
[TBL] [Abstract][Full Text] [Related]
18. Bilateral Optic Neuritis Secondary to Nivolumab Therapy: A Case Report.
Kartal Ö; Ataş E
Medicina (Kaunas); 2018 Nov; 54(5):. PubMed ID: 30404191
[TBL] [Abstract][Full Text] [Related]
19. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
Prevel R; Colin G; Calès V; Renault PA; Mazieres J
Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
[TBL] [Abstract][Full Text] [Related]
20. Case 30-2019: A 65-Year-Old Woman with Lung Cancer and Chest Pain.
Guiney TE; Lopes MS; Kalra MK; Mooradian MJ; Neilan TG; Stone JR
N Engl J Med; 2019 Sep; 381(13):1268-1277. PubMed ID: 31553841
[No Abstract] [Full Text] [Related]
[Next] [New Search]